BioVersys AG (BIOV) Stock Forecast & Price Target

Compare

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BIOV Analyst Ratings

Moderate Buy

2 Buy

0 Hold

0 Sell

Based on 2 analysts giving stock ratings to

BioVersys

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BIOV Stock 12 Month Forecast

Average Price Target

CHF44.00

▲(93.83% Upside)

Based on 2 Wall Street analysts offering 12 month price targets for BioVersys AG in the last 3 months. The average price target is CHF44.00 with a high forecast of CHF48.00 and a low forecast of CHF40.00. The average price target represents a 93.83% change from the last price of CHF22.70.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"21":"CHF21","28":"CHF28","35":"CHF35","42":"CHF42","49":"CHF49"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":48,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF48.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":44,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF44.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF40.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[21,28,35,42,49],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.3,24.276923076923076,26.253846153846155,28.23076923076923,30.20769230769231,32.184615384615384,34.16153846153846,36.13846153846154,38.11538461538461,40.09230769230769,42.06923076923077,44.04615384615384,46.02307692307692,{"y":48,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.3,23.96923076923077,25.638461538461538,27.307692307692307,28.97692307692308,30.646153846153844,32.315384615384616,33.98461538461538,35.65384615384615,37.323076923076925,38.99230769230769,40.661538461538456,42.330769230769235,{"y":44,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.3,23.661538461538463,25.023076923076925,26.384615384615387,27.746153846153845,29.10769230769231,30.46923076923077,31.83076923076923,33.19230769230769,34.55384615384615,35.91538461538462,37.276923076923076,38.63846153846154,{"y":40,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":33.48,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.48,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.48,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.48,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.48,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.48,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.48,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.48,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.48,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":35.38,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":35.38,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.9,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.3,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF48.00

Average Price TargetCHF44.00

Lowest Price TargetCHF40.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Xian Deng

UBS

CHF48

Buy

111.45%

Upside

Initiated

12/11/25

BioVersys AG (BIOV) Receives a Buy from UBS

Ram Selvaraju

H.C. Wainwright

CHF40

Buy

76.21%

Upside

Initiated

12/08/25

BioVersys AG (BIOV) Initiated with a Buy at H.C. Wainwright

Jelena Milovic

Citi

Not Ranked

Citi

CHF62

Buy

173.13%

Upside

Initiated

04/04/25

Citi starts BioVersys AG (BIOV:SW) at BuyCiti analyst Jelena Milovic initiates coverage on BioVersys AG (BIOV:SW) with a Buy rating and a price target of CHF62.00.

Clémence Thiers

Stifel Nicolaus

CHF70

Buy

208.37%

Upside

Reiterated

03/26/25

BioVersys AG: Positioned for Growth with Strong Financials and Promising Pipeline

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Xian Deng

UBS

CHF48

Buy

111.45%

Upside

Initiated

12/11/25

BioVersys AG (BIOV) Receives a Buy from UBS

Ram Selvaraju

H.C. Wainwright

CHF40

Buy

76.21%

Upside

Initiated

12/08/25

BioVersys AG (BIOV) Initiated with a Buy at H.C. Wainwright

Jelena Milovic

Citi

Not Ranked

Citi

CHF62

Buy

173.13%

Upside

Initiated

04/04/25

Citi starts BioVersys AG (BIOV:SW) at BuyCiti analyst Jelena Milovic initiates coverage on BioVersys AG (BIOV:SW) with a Buy rating and a price target of CHF62.00.

Clémence Thiers

Stifel Nicolaus

CHF70

Buy

208.37%

Upside

Reiterated

03/26/25

BioVersys AG: Positioned for Growth with Strong Financials and Promising Pipeline

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioVersys AG

3 Months

xxx

Success Rate

0/1 ratings generated profit

Average Return

-0.80%

initiated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -0.80% per trade.

1 Year

Ram SelvarajuH.C. Wainwright

Success Rate

0/1 ratings generated profit

Average Return

-0.80%

initiated a buy rating last month

Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -0.80% per trade.

2 Years

xxx

Success Rate

0/1 ratings generated profit

Average Return

-0.80%

initiated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -0.80% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BIOV Analyst Recommendation Trends

Rating

Mar 25

Apr 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BIOV has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BIOV average Analyst price target in the past 3 months is 44.00.

Each month's total comprises the sum of three months' worth of ratings.

BIOV Financial Forecast

BIOV Earnings Forecast

Next quarter’s earnings estimate for BIOV is -CHF1.07 with a range of -CHF1.07 to -CHF1.07. The previous quarter’s EPS was -CHF2.05. BIOV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year BIOV has Performed in-line its overall industry.

BIOV Sales Forecast

Next quarter’s sales forecast for BIOV is CHF300.00K with a range of CHF300.00K to CHF300.00K. The previous quarter’s sales results were CHF479.86K. BIOV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year BIOV has Performed in-line its overall industry.

BIOV Stock Forecast FAQ

What is CH:BIOV’s average 12-month price target, according to analysts?

Based on analyst ratings, BioVersys AG’s 12-month average price target is 44.00.

What is CH:BIOV’s upside potential, based on the analysts’ average price target?

BioVersys AG has 93.83% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is BioVersys AG a Buy, Sell or Hold?

BioVersys AG has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.

What is BioVersys AG’s share price target?

The average share price target for BioVersys AG is 44.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF48.00 ,and the lowest forecast is CHF40.00. The average share price target represents 93.83% Increase from the current price of CHF22.7.

What do analysts say about BioVersys AG?

BioVersys AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

How can I buy shares of BioVersys AG?

To buy shares of CH:BIOV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

BioVersys AG (BIOV) Stock Forecast & Price Target

BIOV Analyst Ratings

BIOV Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering BioVersys AG

BIOV Analyst Recommendation Trends

BIOV Financial Forecast

BIOV Earnings Forecast

BIOV Sales Forecast

BIOV Stock Forecast FAQ

Detailed List of Analyst Forecasts